Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (401-410 of 13,978) with videos related to

Pageof 1,398
Sort By:
Leukemia|September 19, 2008
Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trialE Willems, F Baron, E Baudoux, et al.
Leukemia|September 12, 2008
ICER expression inhibits leukemia phenotype and controls tumor progressionM Pigazzi, E Manara, E Baron, et al.
Leukemia|September 12, 2008
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cellsC Nishioka, T Ikezoe, J Yang, et al.
Leukemia|August 23, 2008
Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesisK Schmiegelow, T Vestergaard, S M Nielsen, et al.
Leukemia|July 4, 2008
Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signalingB A Cardoso, L R Martins, C I Santos, et al.
Leukemia|July 4, 2008
Evidence and expertise in the management of polycythemia vera and essential thrombocythemiaG Finazzi, T Barbui
Leukemia|July 4, 2008
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cellsP Pérez-Galán, G Roué, M López-Guerra, et al.
Leukemia|July 4, 2008
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemC L H Snozek, J A Katzmann, R A Kyle, et al.
Leukemia|July 4, 2008
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinibC Yang, P Lu, F Y Lee, et al.
Leukemia|July 18, 2008
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell linesZ Diaz, K K Mann, S Marcoux, et al.
Pageof 1,398

Showing results (401-410 of 13,978) with videos related to

Sort By:
Pageof 1,398
Leukemia|September 19, 2008
Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trialE Willems, F Baron, E Baudoux, et al.
Leukemia|September 12, 2008
ICER expression inhibits leukemia phenotype and controls tumor progressionM Pigazzi, E Manara, E Baron, et al.
Leukemia|September 12, 2008
Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cellsC Nishioka, T Ikezoe, J Yang, et al.
Leukemia|August 23, 2008
Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesisK Schmiegelow, T Vestergaard, S M Nielsen, et al.
Leukemia|July 4, 2008
Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signalingB A Cardoso, L R Martins, C I Santos, et al.
Leukemia|July 4, 2008
Evidence and expertise in the management of polycythemia vera and essential thrombocythemiaG Finazzi, T Barbui
Leukemia|July 4, 2008
BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cellsP Pérez-Galán, G Roué, M López-Guerra, et al.
Leukemia|July 4, 2008
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemC L H Snozek, J A Katzmann, R A Kyle, et al.
Leukemia|July 4, 2008
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinibC Yang, P Lu, F Y Lee, et al.
Leukemia|July 18, 2008
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell linesZ Diaz, K K Mann, S Marcoux, et al.
Pageof 1,398